- Home
- BBD vs IQV Comparison
BBD vs IQV Comparison
Compare BBD & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- IQV
- Stock Information
- Founded
- BBD 1943
- IQV 1982
- Country
- BBD Brazil
- IQV United States
- Employees
- BBD N/A
- IQV N/A
- Industry
- BBD Major Banks
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BBD Finance
- IQV Health Care
- Exchange
- BBD Nasdaq
- IQV Nasdaq
- Market Cap
- BBD 28.8B
- IQV 26.7B
- IPO Year
- BBD N/A
- IQV 2013
- Fundamental
- Price
- BBD $2.80
- IQV $136.91
- Analyst Decision
- BBD Strong Buy
- IQV Buy
- Analyst Count
- BBD 3
- IQV 20
- Target Price
- BBD $2.55
- IQV $226.80
- AVG Volume (30 Days)
- BBD 47.3M
- IQV 2.6M
- Earning Date
- BBD 05-08-2025
- IQV 05-06-2025
- Dividend Yield
- BBD 2.35%
- IQV N/A
- EPS Growth
- BBD 44.93
- IQV 0.26
- EPS
- BBD 0.31
- IQV 7.35
- Revenue
- BBD $14,585,863,742.00
- IQV $15,497,000,000.00
- Revenue This Year
- BBD $68.75
- IQV $5.40
- Revenue Next Year
- BBD $8.99
- IQV $5.21
- P/E Ratio
- BBD $8.31
- IQV $18.65
- Revenue Growth
- BBD 23.20
- IQV 2.84
- 52 Week Low
- BBD $1.84
- IQV $134.65
- 52 Week High
- BBD $2.96
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- BBD 69.02
- IQV 36.95
- Support Level
- BBD $2.72
- IQV $137.34
- Resistance Level
- BBD $2.83
- IQV $145.78
- Average True Range (ATR)
- BBD 0.08
- IQV 5.73
- MACD
- BBD 0.01
- IQV -0.53
- Stochastic Oscillator
- BBD 94.74
- IQV 10.35
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. Banking provides roughly 70% of profits, while the insurance segment contributes the remaining 30%. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.